Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Intervenciones para mejorar el retorno al trabajo en pacientes con depresión

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD006237.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 03 diciembre 2014see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud laboral

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Karen Nieuwenhuijsen

    Correspondencia a: Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

    [email protected]

  • Babs Faber

    Coronel Institute of Occupational Health/Dutch Research Center for Insurance Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Jos H Verbeek

    Cochrane Occupational Safety and Health Review Group, Finnish Institute of Occupational Health, Kuopio, Finland

  • Angela Neumeyer‐Gromen

    Deutsche Krankenhausgesellschaft (The German Hospital Federation), Berlin, Germany

  • Hiske L Hees

    Program for Mood Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Arco C Verhoeven

    NVAB Centre of Excellence, Netherlands Society of Occupational Medicine, Utrecht, Netherlands

  • Christina M van der Feltz‐Cornelis

    Department Tranzo, Faculty of Social and Behavioural Sciences, Tilburg University, Tilburg, Netherlands

  • Ute Bültmann

    Department of Health Sciences, Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Contributions of authors

Original review

KN wrote the initial draft of the protocol and will write subsequent drafts of the protocol and review. She and AN designed and conducted the search strategy. AV, UB, CF, AN, and JV contributed to the draft version of the protocol and contributed to subsequent versions and revisions of the protocol and review. KN, AV, and UB included eligible studies. UB and CF conducted the quality assessment of eligible studies. KN and AN extracted the data from the original studies. KN, CF, and JV conducted the data synthesis.

Update 2014

BF adapted the search strategy and conducted the searches. BF, KN, CF, UB, and AV checked resulting studies for eligibility. BF, KN, AN, AV CF, HH, and UB conducted data extraction. BF, KN, AN, AV, CH, HH, UB, and JV assessed included studies for risk of bias. BF, KN, and JV ran the analyses. KN wrote the draft of the updated review and all others commented on this draft. JV acted as an advisor on the whole review process and several specific topics such as meaningful comparisons, GRADE, and meta‐analysis.

Sources of support

Internal sources

  • Coronel Institute of Occupational Health, Netherlands.

    Salary for Karen Nieuwenhuijsen and Babs Faber

  • Trimbos Instituut ‐ Netherlands Institute of Mental Health and Addiction, Netherlands.

    Salary for Christina van der Feltz‐Cornelis

  • Federal Institute for Occupational Safety and Health, Germany.

    Salary for Angela Neumeyer‐Gromen

  • Finnish Institute of Occupational Health, Finland.

    Salary for Jos Verbeek

  • University Medical Center Groningen, Netherlands.

    Salary for Ute Bültmann

  • Dutch Research Center for Insurance Medicine, Netherlands.

    Support and training for authors

External sources

  • KIS programme, Ministry of Social Affairs and Employment, Netherlands.

    A small grant to Karen Nieuwenhuijsen to help her finish the first version of this review

Declarations of interest

Karen Nieuwenhuijsen was an author of one of the included studies: Noordik 2013.

Babs Faber: none known.

Jos Verbeek: none known.

Angela Neumeyer‐Gromen: none known.

Hiske Hees was an author of one of the included studies: Hees 2013.

Arco Verhoeven: none known.

Christina van der Feltz‐Cornelis was an author of one of the included studies: Vlasveld 2013. Her employer received an unrestricted grant from Eli Lilly for an investigator‐initiated trial on depression and pain. She also received payment from Benecke for speaking at a symposium on chronic pain. She has received royalties from various publishers on her books on psychiatry.

Ute Bültmann: none known.

None of the authors assessed studies they were authors of for eligibility or risk of bias.

Acknowledgements

We are grateful to José Luis Fernandez, Martin Keller, Tony Kendrick, Paul Knekt, Paul McCrone, Judith Proudfoot, Renee Romeo, Kathryn Rost, Aart Schene, Gregory Simon, Alan Wade, Penny Bee, Clément Francois, Nicholas Moore, and Ken Wells for kindly providing further information about their studies. We thank the CCDAN group for their support with the first version of this review. We thank Janet Wale for copy editing the text of the updated review. To conclude, we are very grateful for the help of the Cochrane Occupational Safety and Health Review Group and Jani Ruotsalainen in particular.

Version history

Published

Title

Stage

Authors

Version

2020 Oct 14

Interventions to improve return to work in depressed people

Review

Karen Nieuwenhuijsen, Jos H Verbeek, Angela Neumeyer-Gromen, Arco C Verhoeven, Ute Bültmann, Babs Faber

https://doi.org/10.1002/14651858.CD006237.pub4

2014 Dec 03

Interventions to improve return to work in depressed people

Review

Karen Nieuwenhuijsen, Babs Faber, Jos H Verbeek, Angela Neumeyer‐Gromen, Hiske L Hees, Arco C Verhoeven, Christina M van der Feltz‐Cornelis, Ute Bültmann

https://doi.org/10.1002/14651858.CD006237.pub3

2008 Apr 23

Interventions to improve occupational health in depressed people

Review

Karen Nieuwenhuijsen, Ute Bültmann, Angela Neumeyer‐Gromen, Arco C Verhoeven, Jos H Verbeek, Christina M. Feltz‐Cornelis

https://doi.org/10.1002/14651858.CD006237.pub2

2006 Oct 18

Interventions to improve occupational health in depressed people

Protocol

Karen Nieuwenhuijsen, Arco C Verhoeven, Ute Bültmann, Angela Neumeyer‐Gromen, C M van der Feltz‐Cornelis, Christina M. Feltz‐Cornelis

https://doi.org/10.1002/14651858.CD006237

Differences between protocol and review

In order to reflect the latest guidance available in the Cochrane Handbook for Systematic Teviews of Interventions, we used the GRADE approach. In the former version of the protocol and the published review, we used the Downs and Black checklist to assess quality, while in this update we used the Cochrane Collaboration’s risk of bias tool. Also, we no longer formally tested heterogeneity but rather assessed the I² statistic. Furthermore, our search strategy was simplified and we no longer handsearched journals as these were indexed in MEDLINE and did not yield additional studies. Instead of searching the CCDAN registers, we now directly searched CENTRAL.

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

PRISMA Study flow diagram of the study selection process.
Figuras y tablas -
Figure 1

PRISMA Study flow diagram of the study selection process.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Work‐directed plus clinical versus clinical alone (medium term), outcome: 1.1 Days of sickness absence.
Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Work‐directed plus clinical versus clinical alone (medium term), outcome: 1.1 Days of sickness absence.

Forest plot of comparison: 5 Any antidepressant medication versus any other antidepressant medication, outcome: 5.1 Days of sickness absence.
Figuras y tablas -
Figure 5

Forest plot of comparison: 5 Any antidepressant medication versus any other antidepressant medication, outcome: 5.1 Days of sickness absence.

Forest plot of comparison: 9 Any psychological versus no intervention or care as usual, outcome: 9.1 Days of sickness absence.
Figuras y tablas -
Figure 6

Forest plot of comparison: 9 Any psychological versus no intervention or care as usual, outcome: 9.1 Days of sickness absence.

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 1.1

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 1 Days of sickness absence.

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 1.2

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 2 Depressive symptoms.

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 3 Work functioning.
Figuras y tablas -
Analysis 1.3

Comparison 1 Work‐directed plus clinical versus clinical alone (medium term), Outcome 3 Work functioning.

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 2.1

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 1 Days of sickness absence.

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 2.2

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 2 Depressive symptoms.

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 3 Work functioning.
Figuras y tablas -
Analysis 2.3

Comparison 2 Work‐directed plus clinical versus clinical alone (long term), Outcome 3 Work functioning.

Comparison 3 Work‐directed plus clinical versus work‐directed (medium term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 3.1

Comparison 3 Work‐directed plus clinical versus work‐directed (medium term), Outcome 1 Days of sickness absence.

Comparison 3 Work‐directed plus clinical versus work‐directed (medium term), Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 3.2

Comparison 3 Work‐directed plus clinical versus work‐directed (medium term), Outcome 2 Depressive symptoms.

Comparison 4 Any work‐directed versus alternative work‐directed, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 4.1

Comparison 4 Any work‐directed versus alternative work‐directed, Outcome 1 Days of sickness absence.

Comparison 4 Any work‐directed versus alternative work‐directed, Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 4.2

Comparison 4 Any work‐directed versus alternative work‐directed, Outcome 2 Depressive symptoms.

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 5.1

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 1 Days of sickness absence.

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 5.2

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 2 Depressive symptoms.

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 3 Work functioning.
Figuras y tablas -
Analysis 5.3

Comparison 5 Any antidepressant medication versus any other antidepressant medication, Outcome 3 Work functioning.

Comparison 6 Any antidepressant medication versus placebo, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 6.1

Comparison 6 Any antidepressant medication versus placebo, Outcome 1 Days of sickness absence.

Comparison 6 Any antidepressant medication versus placebo, Outcome 2 Work functioning.
Figuras y tablas -
Analysis 6.2

Comparison 6 Any antidepressant medication versus placebo, Outcome 2 Work functioning.

Comparison 7 Any psychological versus other psychological (medium term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 7.1

Comparison 7 Any psychological versus other psychological (medium term), Outcome 1 Days of sickness absence.

Comparison 7 Any psychological versus other psychological (medium term), Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 7.2

Comparison 7 Any psychological versus other psychological (medium term), Outcome 2 Depressive symptoms.

Comparison 7 Any psychological versus other psychological (medium term), Outcome 3 Work functioning.
Figuras y tablas -
Analysis 7.3

Comparison 7 Any psychological versus other psychological (medium term), Outcome 3 Work functioning.

Comparison 8 Any psychological versus other psychological (long term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 8.1

Comparison 8 Any psychological versus other psychological (long term), Outcome 1 Days of sickness absence.

Comparison 8 Any psychological versus other psychological (long term), Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 8.2

Comparison 8 Any psychological versus other psychological (long term), Outcome 2 Depressive symptoms.

Comparison 8 Any psychological versus other psychological (long term), Outcome 3 Work functioning.
Figuras y tablas -
Analysis 8.3

Comparison 8 Any psychological versus other psychological (long term), Outcome 3 Work functioning.

Comparison 9 Any psychological versus no intervention or care as usual, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 9.1

Comparison 9 Any psychological versus no intervention or care as usual, Outcome 1 Days of sickness absence.

Comparison 9 Any psychological versus no intervention or care as usual, Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 9.2

Comparison 9 Any psychological versus no intervention or care as usual, Outcome 2 Depressive symptoms.

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 10.1

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 1 Days of sickness absence.

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 2 Work functioning or productivity.
Figuras y tablas -
Analysis 10.2

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 2 Work functioning or productivity.

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 3 Depressive symptoms.
Figuras y tablas -
Analysis 10.3

Comparison 10 Psychological combined with antidepressant medication versus antidepressant medication alone, Outcome 3 Depressive symptoms.

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 11.1

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 1 Days of sickness absence.

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 2 Employment status.
Figuras y tablas -
Analysis 11.2

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 2 Employment status.

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 3 Depressive symptoms.
Figuras y tablas -
Analysis 11.3

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 3 Depressive symptoms.

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 4 Depressed yes/no.
Figuras y tablas -
Analysis 11.4

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 4 Depressed yes/no.

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 5 Work functioning.
Figuras y tablas -
Analysis 11.5

Comparison 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term), Outcome 5 Work functioning.

Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 1 Days of sickness absence.
Figuras y tablas -
Analysis 12.1

Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 1 Days of sickness absence.

Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 2 Depressive symptoms.
Figuras y tablas -
Analysis 12.2

Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 2 Depressive symptoms.

Summary of findings for the main comparison. Work‐directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder

Work‐directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder

Patient or population: Persons with depressive disorder
Settings: Two studies were conducted in outpatient and one in a workplace or Employee Assistance Program
Intervention: Work‐directed intervention plus clinical intervention
Comparison: Clinical intervention alone

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Clinical intervention

Work‐directed intervention plus clinical intervention

Days of sickness absence
Follow up: 4 ‐ 12 months

The mean days of sickness absence in the intervention groups was
0.4 standard deviations lower
(0.66 to 0.14 lower)

SMD ‐0.4 (‐0.66 to ‐0.14)

251
(3 studies)

⊕⊕⊕⊝
moderate1

A standard deviation of 0.5 represents a moderate difference between groups

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; SMD: Standardised Mean Difference

Intervention description:

In two studies, an occupational therapy program focusing on work reintegration, combining modified work and supportive interventions was added to clinical care. In one study a regular Employee Assistance program was expanded and incorporated work coaching and modification.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded one level because N < 400

Figuras y tablas -
Summary of findings for the main comparison. Work‐directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder
Summary of findings 2. Any psychological intervention versus no intervention or care as usual for depressive disorder

Any psychological intervention versus no intervention or care as usual for depressive disorder

Patient or population: Persons with depressive disorder
Settings: One study was conducted in a workplace setting and two in primary care
Intervention: Any psychological intervention versus no intervention or care as usual (medium term)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Care As Usual (CAU)

Any psychological intervention

Days of sickness absence
Follow up: 3 ‐ 8 months

The mean days of sickness absence in the intervention groups was
0.23 standard deviations lower
(0.45 to 0.01 lower)

SMD ‐0.23 (‐0.45 to ‐0.01)

326
(3 studies)

⊕⊕⊕⊝
moderate1

A standard deviation of 0.2 represents a small difference between groups

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CBT: Cognitive‐Behavioral Therapy; CAU: Care As Usual; CI: Confidence interval; SMD: Standardised Mean Difference

Intervention description

All three interventions were cognitive‐behavioral therapy, one by telephone and two online. Each of the interventions were interactive, with therapists or specialised nurses providing feedback.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded one level because N < 400

Figuras y tablas -
Summary of findings 2. Any psychological intervention versus no intervention or care as usual for depressive disorder
Summary of findings 3. Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder

Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder

Patient or population: Persons with depressive disorders
Settings: Two studies were conducted in a primary care and one in a managed care setting
Intervention: Psychological intervention combined with antidepressant medication versus no intervention or usual care (medium term)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Care As Usual (CAU)

Psychological intervention combined with antidepressant medication

Days of sickness absence ‐ Enhanced primary care versus CAU
Follow up: 7 ‐ 12 months

The mean days of sickness absence in the intervention groups was
0.02 standard deviations lower
(0.15 lower to 0.12 higher)

SMD ‐0.02 (‐0.15 to 0.12)

969
(2 studies)

⊕⊕⊝⊝
low1,2

A standard deviation of 0.2 represents a small difference between groups

Days of sickness absence ‐ Telephone outreach and care management program versus CAU
Follow up: mean 12 months

The mean days of sickness absence in the intervention groups was
0.21 standard deviations lower
(0.37 to 0.05 lower)

SMD ‐0.21 (‐0.37 to ‐0.05)

604
(1 study)

⊕⊕⊕⊕
high

A standard deviation of 0.2 represents a small difference between groups

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CAU: Care As Usual; CI: Confidence interval; SMD: Standardised Mean Difference

Intervention description

Enhanced primary care

General practitioners were enrolled in a quality improvement program and were expected to provide enhanced care including antidepressant medication and psychological interventions, according to primary care guidelines.

Telephone outreach and care management

This program systematically assessed needs for treatment, facilitated entry into in‐person treatment (both psychotherapy and antidepressant medication), monitored and supported treatment adherence, and (for those declining in‐person treatment) provided a structured psychotherapy intervention by telephone.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Downgraded with one level because all studies were of low quality
2 Downgraded with one level because in one study allocation concealment not adequate

Figuras y tablas -
Summary of findings 3. Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder
Table 1. Quality of the evidence (GRADE)

Comparison

Studies in comparison

Risk of Bias

Inconsistency

Indirectness

Imprecision

Publication bias

Quality of the

evidence

Work‐directed

Work‐directed + clinical intervention versus clinical (medium)

Hees 2013; Lerner 2012; Schene 2006

No: Majority low risk of bias

No: I² < 50%

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Moderate

Work‐directed + clinical intervention versus clinical (long)

Hees 2013; Schene 2006

No: Majority low risk of bias

No: I² < 50%

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Moderate

Work‐directed + clinical versus work‐directed

Vlasveld 2013

No: study with low risk of bias

N.a.

No

Yes:

Single study

Downgrade:

‐1

Undetected

Moderate

Work‐directed versus work‐directed

Noordik 2013

Yes: very serious

Downgrade

‐2

N.a.

No

Yes: wide CI

Downgrade:

‐1

Undetected

Very low

Clinical, medication

Medication:

SSRI versus SNRI

Fernandez 2005; Romeo 2004; Wade 2008

Fernandez: low

Romeo: high

Wade: high

Yes: 83%, pooling not feasible

No

Yes:

Single studies

Downgrade:

‐1

Undetected

Fernandez: moderate

Romeo: Low

Wade: Low

SSRI versus TCA

Miller 1998

Yes: very serious

Downgrade ‐2

N.a.

No

No

Undetected

Low

SSRI versus SSRI

Fantino 2007

No: study with low risk of bias

N.a.

No

Yes:

N< ‐400

Downgrade: ‐1

Undetected

Moderate

TCA or MAO versus placebo

Agosti 1991

Yes: very serious

Downgrade ‐2

N.a.

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Very low

Clinical, psychological

Any psych versus other psych (medium)

Knekt 2013 (three arms)

Yes: serious Downgrade ‐1

Yes: 99% pooling not feasible

No

Yes: single study arms

Downgrade ‐1

Undetected

Knekt I: Low

Knekt II: Low

Any psych versus other psych (medium)

Knekt 2013 (three arms)

Yes: serious Downgrade ‐1

Yes: 99% pooling not feasible

No

Yes: single study arms

Downgrade ‐1

Undetected

Knekt I: Low

Knekt II: Low

Any psych versus CAU

Bee 2010; Hollinghurst 2010; McCrone 2004

No: Majority low risk of bias

No: I² < 50%

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Moderate

CMHN versus CAU

Kendrick 2005 (three arms)

Yes: serious Downgrade ‐1

No: I² < 50%

No

Yes: wide CI

Downgrade:

‐1

Undetected

Low

Clinical, psychological and medication

Psych + med versus medicine

Burnand 2002

Yes: very serious

Downgrade

‐2

N.a.

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Very low

Enhanced primary care versus CAU

Rost 2004; Schoenbaum 2001; Simon 1998

Yes: very serious

Downgrade

‐2

No: I² < 50%

No

No

Undetected

Low

Telephone outreach versus CAU

Wang 2007

No: study with low risk of bias

N.a.

No

No (n > 400 * CI not wide)

Undetected

High

Clinical, exercise

Strength versus relax

Krogh 2009

Yes: serious Downgrade ‐1

N.a.

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Low

Aerobic versus relax or stretching

Krogh 2009; Krogh 2012

No: Majority low risk of bias

No: I² < 50%

No

Yes:

N < ‐400

Downgrade: ‐1

Undetected

Moderate

Figuras y tablas -
Table 1. Quality of the evidence (GRADE)
Comparison 1. Work‐directed plus clinical versus clinical alone (medium term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

3

251

Std. Mean Difference (IV, Random, 95% CI)

‐0.40 [‐0.66, ‐0.14]

1.1 Occupational therapy plus CAU vs. CAU

2

179

Std. Mean Difference (IV, Random, 95% CI)

‐0.30 [‐0.61, 0.01]

1.2 Multi‐component work‐focused program vs. CAU

1

72

Std. Mean Difference (IV, Random, 95% CI)

‐0.66 [‐1.15, ‐0.16]

2 Depressive symptoms Show forest plot

3

251

Std. Mean Difference (IV, Random, 95% CI)

‐0.32 [‐0.88, 0.25]

2.1 Occupational therapy plus CAU vs. CAU

2

179

Std. Mean Difference (IV, Random, 95% CI)

‐0.08 [‐0.66, 0.50]

2.2 Multi‐component work‐focused program vs. CAU

1

72

Std. Mean Difference (IV, Random, 95% CI)

‐0.84 [‐1.34, ‐0.33]

3 Work functioning Show forest plot

2

189

Std. Mean Difference (IV, Random, 95% CI)

‐0.31 [‐0.79, 0.16]

3.1 Occupational therapy plus CAU vs. CAU

1

117

Std. Mean Difference (IV, Random, 95% CI)

‐0.09 [‐0.48, 0.29]

3.2 Multi‐component work‐focused program vs. CAU

1

72

Std. Mean Difference (IV, Random, 95% CI)

‐0.58 [‐1.08, ‐0.09]

Figuras y tablas -
Comparison 1. Work‐directed plus clinical versus clinical alone (medium term)
Comparison 2. Work‐directed plus clinical versus clinical alone (long term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

2

179

Std. Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.49, 0.12]

1.1 Occupational therapy plus CAU vs. CAU

2

179

Std. Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.49, 0.12]

2 Depressive symptoms Show forest plot

1

117

Std. Mean Difference (IV, Random, 95% CI)

‐0.63 [‐1.02, ‐0.24]

2.1 Occupational therapy plus CAU vs. CAU

1

117

Std. Mean Difference (IV, Random, 95% CI)

‐0.63 [‐1.02, ‐0.24]

3 Work functioning Show forest plot

1

117

Std. Mean Difference (IV, Random, 95% CI)

‐0.25 [‐0.63, 0.14]

3.1 Occupational therapy plus CAU vs. CAU

1

117

Std. Mean Difference (IV, Random, 95% CI)

‐0.25 [‐0.63, 0.14]

Figuras y tablas -
Comparison 2. Work‐directed plus clinical versus clinical alone (long term)
Comparison 3. Work‐directed plus clinical versus work‐directed (medium term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

126

Std. Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.49, 0.21]

1.1 Collaborative care vs. CAU

1

126

Std. Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.49, 0.21]

2 Depressive symptoms Show forest plot

1

74

Std. Mean Difference (IV, Random, 95% CI)

0.26 [‐0.20, 0.72]

2.1 Collaborative care vs. CAU

1

74

Std. Mean Difference (IV, Random, 95% CI)

0.26 [‐0.20, 0.72]

Figuras y tablas -
Comparison 3. Work‐directed plus clinical versus work‐directed (medium term)
Comparison 4. Any work‐directed versus alternative work‐directed

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

75

Std. Mean Difference (IV, Random, 95% CI)

0.45 [‐0.00, 0.91]

1.1 RTW‐E vs. CAU

1

75

Std. Mean Difference (IV, Random, 95% CI)

0.45 [‐0.00, 0.91]

2 Depressive symptoms Show forest plot

1

40

Std. Mean Difference (IV, Random, 95% CI)

‐0.18 [‐0.84, 0.49]

2.1 RTW‐E vs. CAU

1

40

Std. Mean Difference (IV, Random, 95% CI)

‐0.18 [‐0.84, 0.49]

Figuras y tablas -
Comparison 4. Any work‐directed versus alternative work‐directed
Comparison 5. Any antidepressant medication versus any other antidepressant medication

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

5

Std. Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.1 SSRI vs. SNRI

3

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.2 SSRI vs. TCA

1

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.3 SSRI vs. SSRI

1

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Depressive symptoms Show forest plot

5

1514

Std. Mean Difference (IV, Random, 95% CI)

0.07 [‐0.34, 0.48]

2.1 SSRI vs. SNRI

3

599

Std. Mean Difference (IV, Random, 95% CI)

0.18 [‐0.37, 0.73]

2.2 SSRI vs. TCA

1

635

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 SSRI vs. SSRI

1

280

Std. Mean Difference (IV, Random, 95% CI)

‐0.23 [‐0.47, 0.00]

3 Work functioning Show forest plot

1

635

Mean Difference (IV, Random, 95% CI)

‐0.05 [‐0.16, 0.06]

3.1 SSRI vs. TCA

1

635

Mean Difference (IV, Random, 95% CI)

‐0.05 [‐0.16, 0.06]

Figuras y tablas -
Comparison 5. Any antidepressant medication versus any other antidepressant medication
Comparison 6. Any antidepressant medication versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

61

Std. Mean Difference (IV, Random, 95% CI)

0.48 [‐0.05, 1.00]

1.1 TCA or MAO vs. placebo

1

61

Std. Mean Difference (IV, Random, 95% CI)

0.48 [‐0.05, 1.00]

2 Work functioning Show forest plot

1

61

Std. Mean Difference (IV, Random, 95% CI)

‐0.58 [‐1.11, ‐0.05]

2.1 TCA or MAO vs. placebo

1

61

Std. Mean Difference (IV, Random, 95% CI)

‐0.58 [‐1.11, ‐0.05]

Figuras y tablas -
Comparison 6. Any antidepressant medication versus placebo
Comparison 7. Any psychological versus other psychological (medium term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

Std. Mean Difference (IV, Random, 95% CI)

Totals not selected

1.1 Short‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 Long‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2 Depressive symptoms Show forest plot

1

Std. Mean Difference (IV, Random, 95% CI)

Totals not selected

2.1 Short‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.2 Long‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3 Work functioning Show forest plot

1

Std. Mean Difference (IV, Random, 95% CI)

Totals not selected

3.1 Short‐term psychodynamic therapy vs solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Long‐term psychodynamic therapy vs solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 7. Any psychological versus other psychological (medium term)
Comparison 8. Any psychological versus other psychological (long term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Short‐term psychodynamic therapy vs. solution‐focused therapy

1

36

Std. Mean Difference (IV, Random, 95% CI)

‐0.91 [‐1.62, ‐0.19]

1.2 Long‐term psychodynamic therapy vs. solution‐focused therapy

1

42

Std. Mean Difference (IV, Random, 95% CI)

‐4.61 [‐5.84, ‐3.39]

2 Depressive symptoms Show forest plot

1

263

Std. Mean Difference (IV, Random, 95% CI)

‐1.85 [‐2.99, ‐0.72]

2.1 Short‐term psychodynamic therapy vs. solution‐focused therapy

1

118

Std. Mean Difference (IV, Random, 95% CI)

‐1.28 [‐1.69, ‐0.86]

2.2 Long‐term psychodynamic therapy vs. solution‐focused therapy

1

145

Std. Mean Difference (IV, Random, 95% CI)

‐2.44 [‐2.90, ‐1.97]

3 Work functioning Show forest plot

1

Std. Mean Difference (IV, Random, 95% CI)

Totals not selected

3.1 Short‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Long‐term psychodynamic therapy vs. solution‐focused therapy

1

Std. Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 8. Any psychological versus other psychological (long term)
Comparison 9. Any psychological versus no intervention or care as usual

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

4

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Online/telephone CBT vs. CAU

3

326

Std. Mean Difference (IV, Random, 95% CI)

‐0.23 [‐0.45, ‐0.01]

1.2 CMHN vs. usual GP care

1

59

Std. Mean Difference (IV, Random, 95% CI)

0.22 [‐0.36, 0.79]

2 Depressive symptoms Show forest plot

4

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

2.1 Online/telephone CBT vs. CAU

3

408

Std. Mean Difference (IV, Random, 95% CI)

‐0.56 [‐0.76, ‐0.36]

2.2 CMHN vs. usual GP care

1

78

Std. Mean Difference (IV, Random, 95% CI)

0.22 [‐0.31, 0.75]

Figuras y tablas -
Comparison 9. Any psychological versus no intervention or care as usual
Comparison 10. Psychological combined with antidepressant medication versus antidepressant medication alone

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

1

57

Std. Mean Difference (IV, Random, 95% CI)

‐0.71 [‐1.25, ‐0.17]

1.1 Psychodynamic therapy plus TCA vs. TCA

1

57

Std. Mean Difference (IV, Random, 95% CI)

‐0.71 [‐1.25, ‐0.17]

2 Work functioning or productivity Show forest plot

1

57

Std. Mean Difference (IV, Random, 95% CI)

‐0.49 [‐1.02, 0.04]

2.1 Psychodynamic therapy plus TCA vs. TCA

1

57

Std. Mean Difference (IV, Random, 95% CI)

‐0.49 [‐1.02, 0.04]

3 Depressive symptoms Show forest plot

1

74

Std. Mean Difference (IV, Random, 95% CI)

‐0.11 [‐0.57, 0.35]

Figuras y tablas -
Comparison 10. Psychological combined with antidepressant medication versus antidepressant medication alone
Comparison 11. Psychological combined with antidepressant medication versus no intervention or usual care (medium term)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

3

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Enhanced primary care vs. CAU

2

969

Std. Mean Difference (IV, Random, 95% CI)

‐0.02 [‐0.15, 0.12]

1.2 Telephone outreach and care management program vs. CAU

1

604

Std. Mean Difference (IV, Random, 95% CI)

‐0.21 [‐0.37, ‐0.05]

2 Employment status Show forest plot

1

1356

Risk Ratio (M‐H, Random, 95% CI)

1.08 [0.99, 1.18]

2.1 Enhanced primary care vs. CAU

1

1356

Risk Ratio (M‐H, Random, 95% CI)

1.08 [0.99, 1.18]

3 Depressive symptoms Show forest plot

2

693

Std. Mean Difference (IV, Random, 95% CI)

‐0.22 [‐0.37, ‐0.07]

3.1 Enhanced primary care vs. CAU

1

89

Std. Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.56, 0.28]

3.2 Telephone outreach and care management program vs. CAU

1

604

Std. Mean Difference (IV, Random, 95% CI)

‐0.23 [‐0.39, ‐0.07]

4 Depressed yes/no Show forest plot

1

1356

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.81, 0.98]

4.1 Enhanced primary care vs. CAU

1

1356

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.81, 0.98]

5 Work functioning Show forest plot

1

604

Std. Mean Difference (IV, Random, 95% CI)

0.50 [0.34, 0.66]

5.1 Telephone outreach and care management program vs. CAU

1

604

Std. Mean Difference (IV, Random, 95% CI)

0.50 [0.34, 0.66]

Figuras y tablas -
Comparison 11. Psychological combined with antidepressant medication versus no intervention or usual care (medium term)
Comparison 12. Exercise intervention versus no intervention or care as usual

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Days of sickness absence Show forest plot

2

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Supervised strength training vs. relaxation

1

65

Std. Mean Difference (IV, Random, 95% CI)

‐1.11 [‐1.68, ‐0.54]

1.2 Aerobic exercise vs. relaxation/stretching

2

180

Std. Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.36, 0.24]

2 Depressive symptoms Show forest plot

2

Std. Mean Difference (IV, Random, 95% CI)

Subtotals only

2.1 Supervised strength training vs. relaxation

1

65

Std. Mean Difference (IV, Random, 95% CI)

0.15 [‐0.39, 0.68]

2.2 Aerobic exercise vs. relaxation/stretching

2

180

Std. Mean Difference (IV, Random, 95% CI)

0.18 [‐0.12, 0.48]

Figuras y tablas -
Comparison 12. Exercise intervention versus no intervention or care as usual